Our GHK-Cu pen holds 50 mg in 3 ml as a pre-loaded multi-dose pen. The important thing about a GHK-Cu product is that it contains the defined complex of GHK and copper(II), that the quantity is documented, and that both are evidenced per batch. Do not rely on marketing copy for that — including ours. For every batch we publish the independent certificate of analysis at /coa.
GHK-Cu is chemically well described. The clinical evidence is heavily dependent on formulation and route, and this is where most pages about it overreach. Cell and animal models examined collagen markers and wound healing. Small human studies concerned topical programmes or a specific wound gel. None of that establishes results for an injectable pen, and we say so ourselves. Stimulation of collagen synthesis in fibroblast cultures by GHK-Cu. PMID 3169264; GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. PMC4508379; The potential of GHK as an anti-aging peptide. PMC8789089; The human tripeptide GHK and tissue remodeling. PMID 18644225
What GHK-Cu actually is
GHK stands for glycyl-L-histidyl-L-lysine, a tripeptide of three amino acids. It binds copper(II), and under physiological conditions the literature supports a defined 1:1 coordination complex. GHK-Cu is therefore not “copper plus a peptide” — it is a specific complex, and its behaviour follows from that.
It was isolated in 1973 by Pickart as an activity in human albumin. The molecule occurs naturally in human plasma, and reported levels decline with age: an average around 200 ng/ml at age 20 falling to roughly 80 ng/ml by 60. That decline is the observation the regenerative interest is built on, and the reason it appears under peptides for longevity.
Natural occurrence is not a safety argument. That a molecule exists in plasma at nanogram concentrations does not establish the safety of a manufactured, far higher-concentration, differently administered form — a distinction worth holding onto when reading any page about this compound.
What the laboratory evidence shows
The best-characterised finding is on collagen synthesis in fibroblast culture. Stimulation begins somewhere between 10⁻¹² and 10⁻¹¹ M and reaches a maximum around 10⁻⁹ M — a genuinely low concentration, and one of the reasons the compound attracted attention.
Reviews describe GHK modulating both synthesis and breakdown of collagen and glycosaminoglycans, and influencing metalloproteinases and their inhibitors. It is described as a modulator of several pathways rather than a single-target agonist, which is a different kind of mechanism from most compounds in this catalogue.
These are cell and animal findings. They describe what the molecule does in a dish or a rodent, and that is where their claim ends.
Where the evidence stops
Human work on GHK-Cu has concerned topical skincare programmes and a specific wound gel. Those studies address the formulations they used. They do not establish wrinkle reduction, hair growth, or the benefit and long-term safety of an injectable pen — and pages that cite topical results underneath an injectable product are borrowing evidence that does not transfer.
Formulation is not incidental here. Properties depend on pH, concentration, counter-ions and the rest of the preparation, so a cosmetic serum, a clinically studied wound gel and an injectable solution are three different products. We set this out in full at GHK-Cu injectable vs topical copper peptides.
For a topical product there is also a penetration question — whether a peptide-sized molecule crosses the stratum corneum in meaningful quantity. Injection removes that question and removes the barrier along with it. Neither route is straightforwardly better; they trade different problems.
What to verify on any GHK-Cu product
A product that can be assessed shows more than a milligram figure. These are the points you can check against our batch certificate:
- the exact chemical designation of the GHK–copper complex or salt;
- total content and fill volume;
- an unambiguous batch number matching the pen in your hand;
- identity testing by an appropriate method;
- quantitative content determination;
- purity, with the method and specification stated;
- evidence of the copper component and a plausible ratio to the peptide;
- sterility, since this is an injectable presentation.
The copper ratio matters specifically for this compound. GHK-Cu is a complex, and a certificate that documents the peptide without addressing copper has characterised half the product. More on reading these documents at how to read a certificate of analysis and batch and lot matching.
Regulatory position
GHK-Cu holds no marketing authorisation as a medicine. Topical cosmetic formulations containing it are regulated as cosmetics, which is a different framework with different requirements — cosmetic regulation is not a medicines assessment and does not evaluate injectable use.
Related reading: what is GHK-Cu?, cosmetic peptides, peptides for skin, the stacks that include GHK-Cu.
